Project
Acceleron_A1334-02
Ongoing - recruitment active ยท 2023 until 2026
Rubbert-Roth Andrea, Schmiedeberg Kristin, Bartz-Batliner Mira, Peischl Shirin, Gostic Dragana
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment active
Start Date
2023
End Date
2026
Financing
Others
Brief description/objective
A Phase 1b Randomized, Double-Blind,
Placebo-Controlled, Multiple-Ascending
Dose Study to Evaluate the Safety,
Pharmacokinetics, and Pharmacodynamics
of ACE-1334 Plus Standard of Care in
Participants with Systemic Sclerosis